Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

General Information

Mayne Pharma Group Limited
MYX
http://www.maynepharma.com
Pharmaceuticals
889
787

Current Price Data+

Current Price Open High Low Last Close Volume Price Movement
$1.13 $1.11 $1.14 $1.11 $1.11 956209 $0.02 ( 1.80% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Current Broker Consensus Recommendation

Buy
26/05/2015
3

Company Overview

Business Description
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. MYX also provides contract development and manufacturing services.
Strategy Analysis
--

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2016 F 40.0 5.2 119.1% 21.8 1.0 0.9% 100.0%
2015 F 16.1 2.4 -43.5% 47.7 0.0 0.0% 0.0%
2014 A 24.0 4.2 77.7% 17.8 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2014 A 2015 F 2016 F 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F
Acrux Limited (ACR) $148M 3.0384 -0.6030 0.2729 5.2976 13.3433 10.4829 8.99% 8.88% 8.83%
Mayne Pharma Group (MYX) $872M 1.0457 -0.2428 1.2068 35.4633 46.8354 21.2237 0.00% 0.00% 0.00%
Starpharma (SPL) $249M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.56 46.40 4.16 1.58
Market 1.02 17.20 1.32 1.56
Sector 0.92 14.40 2.99 0.98

Directors

Name Position Start Date
Mr Scott Anthony Richards Chief Executive Officer, Managing Director 13/02/2012
Mr Roger Campbell Corbett Non-Executive Chairman 17/11/2010
Mr Bruce L Mathieson Non-Executive Director 16/02/2007
Mr Ian Frank Scholes Non-Executive Director 17/10/2007
Hon Ron Best Non-Executive Director 26/07/2006
Mr William Phillips Hodges Non-Executive Director 15/11/2012
Professor Bruce G Robinson Non-Executive Director 26/08/2014

Management

Name Position
Mark Cansdale Chief Financial Officer,Company Secretary
Stefan Cross President of Mayne Pharma USA

Substantial Shareholders

Holding Name
0 (7.50%) B L Mathieson
0 (6.30%) TIGA Trading Pty Ltd
0 (5.10%) Westpac Banking Corporation
0 (5.10%) BT Investment Management Limited

Calendar of Events

Date Event
25 February 2016 Report (Interim)
26 August 2015 Report (Prelim)
26 August 2015 Report (Annual)
01 June 2015 Issued Shares
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.